Director/PDMR Shareholding

3 July 2013

e-Therapeutics plc ("e-Therapeutics" or the "Company")

Director/PDMR Shareholding

e-Therapeutics plc (AIM: ETX), the drug discovery and development company with a proprietary platform in network pharmacology, announces that on 3 July 2013 Brad Hoy, Non-Executive Director, sold 17,857 shares at a price of 34 pence per share. Following this transaction he no longer holds any shares in the Company.

.

-Ends-

For more information, please contact:

e-Therapeutics plc

Daniel Elger

Tel: +44 (0) 79 0991 5068

www.etherapeutics.co.uk 

Panmure Gordon (UK) Limited

Corporate Finance: Fred Walsh / Grishma Patel

Corporate Broking: Hannah Woodley

Tel: +44 (0) 20 7886 2500

www.panmure.com